Ischemic Stroke Clinical Trial
Official title:
The Effect of Music Listening in Rehabilitation of Subacute Stroke
Music listening has many positive effects on the brain. This study aims to find out if people with stroke get better results with their rehabilitation if they listen to music during their passive hours. The study is a randomized controlled trial with people who are at a rehabilitation center care after stroke at Tampere University Hospital. The control group gets standard rehabilitation. Music group gets standard rehabilitation and in addition they listen to music one hour a day during four weeks. Physiotherapists, occupational therapists and speech therapists test how well the participant's walking, use of hand and speech improve. The main goal is to find out if the improvement is better with music listening. The study also monitors effects of music listening on mood in rehabilitation.
Status | Not yet recruiting |
Enrollment | 130 |
Est. completion date | December 2026 |
Est. primary completion date | December 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - hemispheric stroke (ischemic or intracerebral hemorrhage) during last 4 weeks OR spinal cord injury in last 6 months, causing a need of intensive rehabilitation Exclusion Criteria: - severe hearing loss preventing music listening - previous condition of neurological disease of dementia that significantly affects daily functions - active drug use or acute psychiatric condition - unable to understand given information and give consent to participate - for spinal cord injury patients: acute traumatic brain injury or stroke |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Maria Sariola |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in lower extremity function | Functional Ambulation Classification | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in lower extremity function | Berg balance scale | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in lower extremity function | 10 m walking test | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in lower extremity function | Timed Up and Go | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in upper extremity function | Box and Block | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in upper extremity function | 9-hole Peg Test | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in upper extremity function | Grip strength | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in upper extremity function | Arm abduction (scale 1-3, 1 = normal, 2 = able to lift between horizontal plane but with at least 30 degrees deficiency, 3 = unable to lift above horizontal plane) | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in speech | Boston Naming Test | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in speech | Western Aphasia Battery | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in speech | Token | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Change in speech | Story based on a nine-frame cartoon (standardized point scale) | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Mood | Visual Analogue Mood Scale | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Mood | Beck Depression Inventory | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Mood | Generalized Anxiety Disorder-7 | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Daily functions | Rivermead Motor Assessment Gross function | At time point 0 and 4-5 weeks later (Before and after intervention) | |
Primary | Daily functions | Functional Status Questionnaire (FSQfin) | At time point 0 and 4-5 weeks later (Before and after intervention) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |